Nafcillin
Approved
Approval ID
4376871a-91c7-4730-b58d-62a2b6915de5
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 18, 2023
Manufacturers
FDA
Methapharm Inc.
DUNS: 066672887
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Nafcillin Injection
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code67850-031
Application NumberANDA090560
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nafcillin Injection
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 14, 2019
FDA Product Classification
INGREDIENTS (1)
NAFCILLIN SODIUMActive
Quantity: 1 g in 1 g
Code: 49G3001BCK
Classification: ACTIM
Nafcillin Injection
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code67850-032
Application NumberANDA090560
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nafcillin Injection
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 14, 2019
FDA Product Classification
INGREDIENTS (1)
NAFCILLIN SODIUMActive
Quantity: 2 g in 2 g
Code: 49G3001BCK
Classification: ACTIM